US 8481521
Methods of treating cell proliferative disorders
granted A61KA61K31/505A61K31/5383
Quick answer
US patent 8481521 (Methods of treating cell proliferative disorders) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/505, A61K31/5383, A61K31/542, A61P